Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$41.65 ?????
So, has anyone else noticed that when OTCX comes out to play the share price always seems to take a dip?
Ok, I think I mixed up the 2-3 days it takes for the Fins to be filed before they go live vs the time it takes for the stop sign/yield sign to go down after fins go live.
Thanks for clearing that up for me.
The timeline I have in my head is Q2 then 2-3 days later Yield sign goes bye bye? Does that sound correct?
Also, was that 800k dip a cover or a dump?
And thanks to whoever for another 50k block of cheapies.
Good luck to all.
That’s what the ignore button is for, unless you have proof to prove him incorrect?
Ever shave a zebra?
Come on, let’s just ease off a little. This isn’t a crusade.
Everyone needs to take what they read here as a grain of salt and base your trades off your own DD.
If you are making trades off what some guy said on “the internet”, I have some land to sell you I Florida...
With all due respect to all here, I think we are all just a little fed up of waiting... In due time we will get our stop sign lifted.
There is always the ignore button if your truly put off by someone speculating.
Wishing all the best of luck!
From the way that I read the past few S-1/As, there are two levels to this subscription, Basic and Over. With Basic, you get a 1:1 match at $1.75 per share. If you fill out the basic subscription, there is the Over-subscription. The over-subscription is a 1:"as many as you want until the shares are gone" also at the $1.75 rate.
So, as I read it, you only need 1 share to be eligible for as many shares as you want at $1.75, that is until the 28m shares are sold.
The other way to get in is to invest $1million or more as an outside investor.
Am I missing anything?
I've not found a selling restriction... have you?
As for how much they will invest, that is all up to them.
I hope your correct!
Sam, currently the offering includes a Basic Subscription and a Over-Subscription...
Note that the S-1 is not final and will most likely will change, again...
Sam, where are you getting these numbers from? Dude only purchased like 3k shares @ around $2.50 give or take. How are you extrapolating $3million? Regardless of their salary, putting money into stock is not to be taken lightly.
Thanks for yet another 50k shares of cheapies!
Was that a huge “dark pool” buy at close?
I don't think so. Insider selling with out proper SEC within 2 days and he's in jail faster then you can say "Martha Stewart".
Thanks to whoever sold me another 50k cheapies =-)
Not every day but when the price is right I suck up 50k blocks. Have a nice pool but no where as big as some here have.
Thanks to whoever sold me 50k cheapies @ 71 just before closing
Hope everyone has a nice weekend. GLTA next week!
Einstein is dead.
The definition of “Practice” is the act of doing the same thing over and over with the expectation of improvement.
That is not true, ever practice before? Hope to one day make that 100m sprint time or maybe the 50m butterfly time?
We repeat these events to grow, to tune and to better ourselves.
I took 50k shares today, thanks to whoever let them go
Isn’t that Citadel 500k bid that now is 1m?
And he didn’t say that the paperwork was submitted, just that they were completed... ugggg
From the talk with the CEO last visit, I don’t expect to see financials for 4-8 more weeks. While that sucks, it will be a good thing to get all the bad financial stuff over with so they can move on.
And ignoring the fact brings the sixth horse, ignorance.
Yea... DCTH killed people and DCTH didn’t disclose this material info in a timely manner.
To not accept MP means they don’t except MasterCard.
I’ve not gotten a 50k block below 0.089 in the past week or so...
Fake news.
Delcath Announces Ratio for Reverse Split Authorization
8:00 AM ET 5/1/18 | GlobeNewswire
Delcath Announces Ratio for Reverse Split Authorization
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's Board of Directors has authorized a reverse stock split of the Company's common stock at a ratio of 1-for-500 (the Reverse Stock Split Authorization). The Company's Board of Directors was authorized to effect the reverse split by shareholder approval of its Consent Solicitation filed with the Securities Exchange Commission (SEC) on February, 26, 2018. The proposal to effect a reverse split was approved by shareholders on April 6, 2018 by a vote of 52.8%. The reverse split will be effected prior to the initiation of trading on May 2, 2018.
Beginning with the May 2, 2018 trading date, Delcath's shares will be designated by the symbol DCTHD for 20 trading days, and thereafter will revert to the symbol DCTH.
About Delcath Systems
Delcath Systems, Inc. is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product -- Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) -- is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. We have commenced a global Phase 3 FOCUS clinical trial for Patients with Hepatic Dominant Ocular Melanoma (OM) and plan to initiate a Registration trial for intrahepatic cholangiocarcinoma (ICC). Melphalan/HDS has not been approved by the U.S. Food & Drug Administration (FDA) for sale in the U.S. In Europe, our system has been commercially available since 2012 under the trade name Delcath Hepatic CHEMOSAT(R) Delivery System for Melphalan (CHEMOSAT), where it has been used at major medical centers to treat a wide range of cancers of the liver.
Forward Looking Statements
Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to: the timing and results of the Company's clinical trials including without limitation the OM and ICC clinical trial programs, timely enrollment and treatment of patients in the global Phase 3 OM clinical trial, IRB or ethics committee clearance of the Phase 3 OM and ICC Registration trial protocols from participating sites and the timing of site activation and subject enrollment in each trial, the impact of the presentations at major medical conferences and future clinical results consistent with the data presented, approval of Individual Funding Requests for reimbursement of the CHEMOSAT procedure, the impact, if any of ZE reimbursement on potential CHEMOSAT product use and sales in Germany, clinical adoption, use and resulting sales, if any, for the CHEMOSAT system to deliver and filter melphalan in Europe including the key markets of Germany and the UK, the Company's ability to successfully commercialize the Melphalan HDS/CHEMOSAT system and the potential of the Melphalan HDS/CHEMOSAT system as a treatment for patients with primary and metastatic disease in the liver, our ability to obtain reimbursement for the CHEMOSAT system in various markets,, approval of the current or future Melphalan HDS/CHEMOSAT system for delivery and filtration of melphalan or other chemotherapeutic agents for various indications in the U.S. and/or in foreign markets, actions by the FDA or other foreign regulatory agencies, the Company's ability to successfully enter into strategic partnership and distribution arrangements in foreign markets and the timing and revenue, if any, of the same, uncertainties relating to the timing and results of research and development projects, and uncertainties regarding the Company's ability to obtain financial and other resources for any research, development, clinical trials and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.
Contact:
Delcath Investor Relations
Email: investorrelations@delcath.com
> Dow Jones Newswires
May 01, 2018 08:00 ET (12:00 GMT)
While I agree that long posts detract from the content of the message, English is obviously not their first language. 2b does make an effort to improve. Please be a little more compassionate and understanding. I for one only speak English and am not the better for it.
Getting outside ideas is one of the goals of a board like this. As long as the message is true of heart, I’m happy trying my best to interpret.
Good luck to us all.
2b, thank you, the absence of the dash makes it much easier to read.
I agree, there are pump posts, there are dump posts, are due diligence (DD) posts, there are alternative agenda posts and there is noise. It’s difficult to sometimes pick through the mine field looking for the honest opinion or DD.
My best advice is to take everything you read here with a grain of salt. Follow those that you feel give the best DD.
Bottom line, form your own opinion, make your own decision and own your mistakes.
I became interested in this stock after following p.mike. This was my first time posting there. I do a lot more listening then I do talking.
The MM and shorts control this stock.
Until they get their finances in order and get filings done in a timely manner, this stock will continue to struggle.
Letting a stop sign happen is inexcusable.
Good look to you.
2b, pleeeese, for the love of all that is good. Stop with the dash-between-each-word. You seem to only do it on the beginning of your posts. It only retracts from your content and I really don’t want to put you on ignore as you have meaningful and intelligently thought out messages. Honestly, for some reason it gives me a headache.
Calm down, Sam was directly asked his “OPINION”.
Excuse my ignorance, what is the “stop sign” you are referring to?
Sharing my DD into DCTHs requirement for disclosure in regards to RS.
Isn’t that why we are here? To share DD?
GLTY
SEC Rule 10b-17 is the main regulation dealing with stock splits. Rule 10b-17 is an anti-fraud regulation of federal securities law. The regulation requires that issuers of publicly traded securities provide timely notice of certain corporate actions, including stock splits, reverse stock splits and the issuance of dividends. The notice must be provided at least 10 days before the record date for the corporate action. The regulation states that the notice must be provided to the National Association of Securities Dealers (NASD). The Financial Industry Regulatory Authority (FINRA) was created when the NASD merged with the New York Stock Exchanges (NYSE) regulation committee in 2007 and is therefore the successor to the NASD.
Read more: What are the SEC regulations regarding stock splits? | Investopedia https://www.investopedia.com/ask/answers/033015/what-are-sec-regulations-regarding-stock-splits.asp#ixzz5CVSG3oSn
Follow us: Investopedia on Facebook
Sam, What’s stopping her from issuing preferred shares with super voting power like last after the last failed vote?
Wow.... I question 150% of the legitimacy of everything I see on here but you just laid out my feeling about DCTH, in entirety, in an elegant and precise way. Bravo... you took all the words out of my mouth and I stand speechless.
Good luck to us all and may God have mercy on our souls.
I don’t know, maybe you found something false, fake or made up on there that I didn’t???
I would be more compassionate to your point if you did... otherwise we will have to agree to disagree?
I am also a share holder, as you are.
Hope you and the rest of the crew here have a wonderful weekend.
I find no fault, seems to be stating a bunch of public domain info all in one place... must admit, it wouldn’t make a pumper happy. It also might open the eyes to future investors as to the 9th circle of hell as we all know it...
Buyer Beware as they say?